ME Therapeutics Holdings Inc.
METX
CNSX
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -251.40K | -139.70K | -219.10K | -227.90K | -364.00K |
| Total Depreciation and Amortization | 18.30K | 14.30K | 7.60K | 0.00 | 0.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.40K | 15.20K | 113.00K | 124.80K | 225.10K |
| Change in Net Operating Assets | 42.60K | -34.60K | -7.20K | -6.60K | 33.90K |
| Cash from Operations | -188.10K | -144.80K | -105.70K | -109.70K | -104.90K |
| Capital Expenditure | -6.20K | -107.60K | -6.40K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -40.90K | 0.00 | -7.90K | -- | -- |
| Cash from Investing | -47.10K | -107.60K | -14.30K | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -16.30K | -16.30K | -5.40K | 0.00 | 0.00 |
| Issuance of Common Stock | 0.00 | 1.05M | -- | 0.00 | 450.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -7.50K | -- |
| Cash from Financing | -11.60K | 722.30K | -4.00K | -5.50K | 330.20K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -246.80K | 469.80K | -124.00K | -115.20K | 225.30K |